Skip to main content

and
  1. No Access

    Article

    Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors

    In a prospective multicentre study of bloodstream infection (BSI) from November 01, 2007 to July 31, 2010, seven paediatric cancer centres (PCC) from Germany and one from Switzerland included 770 paediatric ca...

    R. A. Ammann, H. J. Laws, D. Schrey, K. Ehlert, O. Moser in European Journal of Pediatrics (2015)

  2. No Access

    Article

    Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases

    The purpose of this study was the appraisal of the clinical and functional consequences of germline mutations within the gene for the IL-2 inducible T-cell kinase, ITK. Among patients with Epstein-Barr virus-d...

    R M Linka, S L Risse, K Bienemann, M Werner, Y Linka, F Krux, C Synaeve in Leukemia (2012)

  3. No Access

    Article

    Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases

    We examined the role of total body magnetic resonance imaging (TB-MRI)-governed involved compartment irradiation (ICI) and high-dose chemotherapy (HDC), followed by stem cell rescue (SCR) in patients with high...

    S Burdach, U Thiel, M Schöniger, R Haase, A Wawer in Bone Marrow Transplantation (2010)

  4. No Access

    Article

    Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation

    Neurological complications are a relevant cause of morbidity and mortality after haematopoietic stem cell transplantation (SCT). We retrospectively analysed neurological complications of 165 paediatric patient...

    C Weber, J Schaper, D Tibussek, O Adams, C R MacKenzie in Bone Marrow Transplantation (2008)

  5. No Access

    Article

    Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey

    Piperacillin-Tazobactam (Pip-Taz) is an evidence-based empirical treatment of febrile neutropenia in adolescents and adults. No data are available in pediatric cancer patients <25 months of age. In this retros...

    A. Simon, T. Lehrnbecher, U. Bode in European Journal of Clinical Microbiology … (2007)

  6. Article

    Erratum: Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

    Correction to: Bone Marrow Transplantation (2004) 33, 189–195. doi:10.1038/sj.bmt.1704329; Published online: 8 December 2003. The author names and affiliations were published incorrectly; the correct version i...

    S Corbacioglu, J Greil, C Peters, N Wulffraat, H J Laws in Bone Marrow Transplantation (2004)

  7. No Access

    Article

    Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

    Veno-occlusive disease (VOD) of the liver is a complication observed particularly in patients undergoing hematopoietic stem cell transplantation (HSCT). Defibrotide (DF) is a polydeoxyribonucleotide with aptam...

    S Corbacioglu, J Greil, C Peters, N Wulffraat, H J Laws in Bone Marrow Transplantation (2004)

  8. Article

    Erratum: High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

    Bone Marrow Transplantation 2003;31:893–898 The authors have realised that a wrong figure was included with the paper above. The correct figure is below (Figure 1).

    B Kremens, B Gruhn, T Klingebiel, C Hasan, H-J Laws in Bone Marrow Transplantation (2003)

  9. No Access

    Article

    High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

    Children with Wilms tumor who have a particular risk of failure at relapse or at primary diagnosis were treated with high-dose chemotherapy (HDC) and autologous peripheral blood stem cell rescue in order to im...

    B Kremens, B Gruhn, T Klingebiel, C Hasan, H-J Laws in Bone Marrow Transplantation (2002)

  10. No Access

    Article

    In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors

    The potent immunostimulatory cytokine interleukin-2 (IL-2) has been extensively investigated for its potential to induce anti-tumor immunity in a number of tumor models. Only recently the complex interplay of ...

    H Bönig, H-J Laws, A Wundes, J Verheyen, M Hannen, Y-M Kim in Bone Marrow Transplantation (2000)

  11. No Access

    Chapter

    Transgenic Expression of IL-2 in Peripheral Neuroectodermal Malignancies of Childhood: In Vitro and In Vivo Effects on Lymphocyte Activation and Tumor Lysis

    Posttransplantational adjuvant interleukin-2 (IL-2) therapy has previously been shown to improve the prognosis of patients with Ewing tumors. This has been attributed to a stimulation of the immune system and ...

    B. C. Engel, H.-J. Laws, S. E. G. Burdach in Transplantation in Hematology and Oncology (2000)

  12. No Access

    Article

    Cure of latex allergy by bone marrow transplantation

    V. Wahn, H.-J. Laws, C.-P. Bode, S. E. G. Burdach in European Journal of Pediatrics (1999)